Jim Cramer's top 10 things to watch in the stock market Tuesday

S&P 500 futures rose as June consumer prices posted their biggest decline in over six years, giving a temporary respite from 2026’s persistent inflation while keeping lawmakers focused on rates. In bank earnings, Wells Fargo beat with EPS of $2.00 vs $1.72 and revenue of $22.62B vs $21.84B, while Goldman Sachs topped expectations on every line (EPS $20.98 vs $14.48 consensus; sales $20.34B vs $16.13B). Tech/AI demand stayed a key driver as KeyBanc raised Intel’s price target to $155 (from $110) on stronger AI-driven server CPU demand, though IBM warned its software/infrastructure business is pressured by clients shifting spending toward AI buildouts. Healthcare and consumer names also moved on analyst actions, with KeyBanc lifting UnitedHealth’s PT to $475 (from $400) while Barclays cut Disney’s PT to $110 (from $135) ahead of earnings.

Analysis

The cleanest first-order winner is the domestic bank complex: better-than-feared credit and expense control matter more than the headline print, but the bigger mechanism is that softer inflation keeps the path open for lower front-end rates without immediately killing loan demand. That is bullish for fee-heavy franchises like GS and BAC, and for WFC because operating leverage is finally showing up; the risk is that a fast decline in yields compresses NIM faster than deposit costs reset. JPM’s modest FICC miss reads as a caution that trading is normalizing, so the best bank exposure is not beta but idiosyncratic execution.

The more important second-order trade is within tech: IBM’s warning is not just an IBM problem, it is evidence that AI capex is cannibalizing legacy software/infrastructure budgets. That shifts spend toward the hardware stack and the supply chain that can actually capture budget now: TSM first, then select compute beneficiaries like INTC if server CPU demand is real rather than a one-quarter pull-forward. If this is a genuine reallocation, the laggards will be the firms selling “optimization” while customers buy boxes.

Healthcare and housing are the slower-burn setup. UNH looks like a near-term beneficiary of moderating utilization, but the catalyst window is Thursday earnings; a good print could rerate managed care quickly if guidance confirms utilization discipline. By contrast, HD and PHM remain hostage to mortgage rates; a softer CPI helps only if the bond market believes growth is intact. DIS remains a low-conviction name until there is a concrete capital-allocation catalyst; absent M&A, the stock is likely to stay in the penalty box while NFLX optionality from deal speculation is being overstated.

Key Decisions for Investors

• Long GS/WFC into earnings follow-through, 1-3 weeks; best risk/reward is for franchises with operating leverage and capital-markets upside, but trim if the 2Y Treasury keeps collapsing and NIM pressure becomes the dominant narrative.
• Long TSM and/or INTC on AI capex rotation, 1-3 months; use IBM weakness as confirmation that enterprise budgets are being reallocated toward hardware. Falsifier: if hyperscaler capex commentary slows or server CPU demand is revised down next quarter.
• Long UNH into Thursday earnings; tactical trade for 3-10 days with upside if utilization stays subdued and guidance is reaffirmed. Falsifier: any sign that medical cost trends are reaccelerating into 2H26.
• Pair trade: long TSM / short IBM for 1-2 months to express AI spend substitution. The thesis breaks if IBM’s software resilience is temporary and IBM’s revisions stabilize while TSM orders soften.
• Avoid chasing DIS or PHM here; both need a real catalyst beyond valuation rhetoric. If DIS announces a credible strategic transaction or PHM beats on rates-sensitive demand, reassess; otherwise the asymmetry favors waiting.